NGM BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 62921N955. A total of 3 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 300 | +200.0% | 0.00% | – |
| Q2 2023 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 100 | -98.9% | 0.00% | – |
| Q3 2022 | $115,000 | +2200.0% | 8,800 | +2833.3% | 0.00% | – |
| Q4 2021 | $5,000 | +25.0% | 300 | +50.0% | 0.00% | – |
| Q3 2021 | $4,000 | +33.3% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -99.3% | 200 | +35.1% | 0.00% | -100.0% |
| Q1 2021 | $430,000 | – | 148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 60,000 | $785,000 | 0.04% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 8,800 | $115,000 | 0.00% |